Abstract |
|
Authors | Tohru Noji, Hitoshi Sato, Jun-ichi Sano, Satoshi Nishikawa, Hideaki Kusaka, Akira Karasawa |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 449
Issue 3
Pg. 293-300
(Aug 09 2002)
ISSN: 0014-2999 [Print] Netherlands |
PMID | 12167472
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 3-(1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl)-1,6-dimethyl-2,4-(1H,3H)-quinazolinedione
- Anti-Inflammatory Agents
- Immunosuppressive Agents
- Neurotransmitter Uptake Inhibitors
- Pyrimidinones
- Quinazolines
- Cyclophosphamide
- Prednisolone
- Alanine Transaminase
- Adenosine
- Bilirubin
|
Topics |
- Adenosine
(metabolism)
- Alanine Transaminase
(metabolism)
- Animals
- Anti-Inflammatory Agents
(therapeutic use)
- Bilirubin
(blood)
- Cyclophosphamide
(therapeutic use)
- Erythrocyte Count
- Glomerular Mesangium
(metabolism)
- Glomerulonephritis
(drug therapy, pathology)
- Immunosuppressive Agents
(therapeutic use)
- Kidney Function Tests
- Kidney Tubules
(metabolism, pathology)
- Male
- Mice
- Neurotransmitter Uptake Inhibitors
(adverse effects, therapeutic use)
- Organ Size
(drug effects)
- Periodic Acid-Schiff Reaction
- Prednisolone
(therapeutic use)
- Pyrimidinones
(adverse effects, therapeutic use)
- Quinazolines
(adverse effects, therapeutic use)
- Rabbits
- Spleen
(drug effects)
- Thymus Gland
(drug effects)
|